1. Noninvasive Stratum Corneum Sampling and Electron Microscopical Examination of Skin Barrier Integrity: Pilot Study with a Topical Glycerin Formulation for Atopic Dermatitis
- Author
-
D. Daehnhardt, S. Daehnhardt-Pfeiffer, C. Surber, K.-P. Wilhelm, G. Springmann, R. Foelster-Holst, and M. Boettcher
- Subjects
Adult ,Glycerol ,Male ,Pathology ,medicine.medical_specialty ,Skin barrier ,Time Factors ,Adolescent ,Physiology ,Chemistry, Pharmaceutical ,Skin Absorption ,Lipid Bilayers ,Pilot Projects ,Dermatology ,Administration, Cutaneous ,Glycerol metabolism ,Permeability ,Dermatitis, Atopic ,Excipients ,Microscopy, Electron, Transmission ,Stratum corneum ,Humans ,Medicine ,Treatment effect ,Sampling (medicine) ,Direct evaluation ,Child ,Skin ,Pharmacology ,integumentary system ,business.industry ,General Medicine ,Atopic dermatitis ,medicine.disease ,medicine.anatomical_structure ,Morphometric analysis ,Female ,Dermatologic Agents ,business - Abstract
Introduction: Therapy of atopic dermatitis encloses use of medicated and nonmedicated preparations. Results of clinical and biophysical procedures indirectly describe the condition of the impaired skin barrier (SB). Direct evaluation of SB integrity is only possible by electron microscopical visualization, e.g. intercellular lipid lamellae (ICLL) organization of the stratum corneum. Method: SB integrity was measured by morphometric analysis of ICLL in healthy and atopic skin and after a 15-day treatment (plus 7-day follow-up) of atopic skin with a glycerin preparation. Results: Significant treatment effect was shown by the restoration of the ICLL. Conclusions: The study reveals that morphometric analysis of ICLL organization is suitable to differentiate between healthy and diseased skin and to semiquantitatively determine the effect of a nonmedicated glycerin formulation. Limitation: Small treatment cohort.
- Published
- 2012